Waldenstrom Macroglobulinemia Arising During Maintenance Therapy of Plasma Cell Myeloma
Clinical Laboratory · 2023
DOI: 10.7754/clin.lab.2022.220527 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Laboratory, 2023. Verfasst von Nana Jin und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Multiple Myeloma, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell.
Abstract (Originalsprache)
BACKGROUND: Both plasma cell myeloma (PCM) and Waldenstrom's macroglobulinemia (WM) are mature B-cell neoplasms commonly involving bone marrow and usually related to paraproteinemia. METHODS: Secondary WM in a patient with PCM during maintenance therapy has not been previously reported. We herein report the first case of WM arising during maintenance therapy of PCM. RESULTS: The diagnosis of secondary WM during maintenance therapy of PCM was based on combination of medical history, morphology, flow cytometry, immunofixation electrophoresis, and molecular genetics. CONCLUSIONS: This case highlights the importance of an integrated diagnostic work-up, with an interesting role for morphology and flow immunotyping.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Jin, N., Ye, P., Chen, C., & Xiao, D. (2023). Waldenstrom Macroglobulinemia Arising During Maintenance Therapy of Plasma Cell Myeloma. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2022.220527
Vancouver
Jin N, Ye P, Chen C, Xiao D. Waldenstrom Macroglobulinemia Arising During Maintenance Therapy of Plasma Cell Myeloma. Clinical Laboratory. 2023. doi:10.7754/clin.lab.2022.220527
BibTeX
@article{Jin2023,
author = {Jin, Nana and Ye, Ping and Chen, Changkun and Xiao, Dejun},
title = {Waldenstrom Macroglobulinemia Arising During Maintenance Therapy of Plasma Cell Myeloma},
journal = {Clinical Laboratory},
year = {2023},
doi = {10.7754/clin.lab.2022.220527}
}
EUVIMED